PMC:7309518 / 8169-8957 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T42","span":{"begin":19,"end":22},"obj":"Body_part"},{"id":"T43","span":{"begin":23,"end":30},"obj":"Body_part"}],"attributes":[{"id":"A42","pred":"fma_id","subj":"T42","obj":"http://purl.org/sig/ont/fma/fma20935"},{"id":"A43","pred":"fma_id","subj":"T43","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":", and plexus, high CSF protein concentration but negative for COVID-19, typical features of acute demyelinating neuropathy by electrophysiology, and clinical improvement after IVIg.11\n\nGBS in the COVID-19 pandemic\nThese early GBS cases, despite incomplete immunologic workup considering the enormous difficulties in highly stressed in-hospital settings, provide early clues on what to expect in the months ahead regarding the common acute autoimmune neurologic conditions, such as GBS, polyneuritis cranialis, encephalitis, encephalomyelitis, or myositis, which for years we have been casually referring to as postviral if seen after febrile illnesses.\nFirst and foremost, the practicing neurologists in this pandemic should now be aware that a patient who presents with an acute paralyti"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T129","span":{"begin":62,"end":70},"obj":"Disease"},{"id":"T130","span":{"begin":112,"end":122},"obj":"Disease"},{"id":"T131","span":{"begin":185,"end":188},"obj":"Disease"},{"id":"T132","span":{"begin":196,"end":204},"obj":"Disease"},{"id":"T133","span":{"begin":226,"end":229},"obj":"Disease"},{"id":"T134","span":{"begin":481,"end":484},"obj":"Disease"},{"id":"T135","span":{"begin":486,"end":498},"obj":"Disease"},{"id":"T136","span":{"begin":510,"end":522},"obj":"Disease"},{"id":"T137","span":{"begin":524,"end":541},"obj":"Disease"},{"id":"T138","span":{"begin":546,"end":554},"obj":"Disease"}],"attributes":[{"id":"A129","pred":"mondo_id","subj":"T129","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A130","pred":"mondo_id","subj":"T130","obj":"http://purl.obolibrary.org/obo/MONDO_0005244"},{"id":"A131","pred":"mondo_id","subj":"T131","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"},{"id":"A132","pred":"mondo_id","subj":"T132","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A133","pred":"mondo_id","subj":"T133","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"},{"id":"A134","pred":"mondo_id","subj":"T134","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"},{"id":"A135","pred":"mondo_id","subj":"T135","obj":"http://purl.obolibrary.org/obo/MONDO_0021718"},{"id":"A136","pred":"mondo_id","subj":"T136","obj":"http://purl.obolibrary.org/obo/MONDO_0019956"},{"id":"A137","pred":"mondo_id","subj":"T137","obj":"http://purl.obolibrary.org/obo/MONDO_0005156"},{"id":"A138","pred":"mondo_id","subj":"T138","obj":"http://purl.obolibrary.org/obo/MONDO_0008054"},{"id":"A139","pred":"mondo_id","subj":"T138","obj":"http://purl.obolibrary.org/obo/MONDO_0021167"}],"text":", and plexus, high CSF protein concentration but negative for COVID-19, typical features of acute demyelinating neuropathy by electrophysiology, and clinical improvement after IVIg.11\n\nGBS in the COVID-19 pandemic\nThese early GBS cases, despite incomplete immunologic workup considering the enormous difficulties in highly stressed in-hospital settings, provide early clues on what to expect in the months ahead regarding the common acute autoimmune neurologic conditions, such as GBS, polyneuritis cranialis, encephalitis, encephalomyelitis, or myositis, which for years we have been casually referring to as postviral if seen after febrile illnesses.\nFirst and foremost, the practicing neurologists in this pandemic should now be aware that a patient who presents with an acute paralyti"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T55","span":{"begin":181,"end":183},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T56","span":{"begin":743,"end":744},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":", and plexus, high CSF protein concentration but negative for COVID-19, typical features of acute demyelinating neuropathy by electrophysiology, and clinical improvement after IVIg.11\n\nGBS in the COVID-19 pandemic\nThese early GBS cases, despite incomplete immunologic workup considering the enormous difficulties in highly stressed in-hospital settings, provide early clues on what to expect in the months ahead regarding the common acute autoimmune neurologic conditions, such as GBS, polyneuritis cranialis, encephalitis, encephalomyelitis, or myositis, which for years we have been casually referring to as postviral if seen after febrile illnesses.\nFirst and foremost, the practicing neurologists in this pandemic should now be aware that a patient who presents with an acute paralyti"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T25","span":{"begin":23,"end":30},"obj":"Chemical"}],"attributes":[{"id":"A25","pred":"chebi_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":", and plexus, high CSF protein concentration but negative for COVID-19, typical features of acute demyelinating neuropathy by electrophysiology, and clinical improvement after IVIg.11\n\nGBS in the COVID-19 pandemic\nThese early GBS cases, despite incomplete immunologic workup considering the enormous difficulties in highly stressed in-hospital settings, provide early clues on what to expect in the months ahead regarding the common acute autoimmune neurologic conditions, such as GBS, polyneuritis cranialis, encephalitis, encephalomyelitis, or myositis, which for years we have been casually referring to as postviral if seen after febrile illnesses.\nFirst and foremost, the practicing neurologists in this pandemic should now be aware that a patient who presents with an acute paralyti"}

{"project":"LitCovid-PubTator","denotations":[{"id":"294","span":{"begin":19,"end":22},"obj":"Gene"},{"id":"322","span":{"begin":62,"end":70},"obj":"Disease"},{"id":"323","span":{"begin":98,"end":122},"obj":"Disease"},{"id":"325","span":{"begin":196,"end":204},"obj":"Disease"},{"id":"330","span":{"begin":486,"end":508},"obj":"Disease"},{"id":"331","span":{"begin":510,"end":522},"obj":"Disease"},{"id":"332","span":{"begin":524,"end":541},"obj":"Disease"},{"id":"333","span":{"begin":546,"end":554},"obj":"Disease"},{"id":"357","span":{"begin":745,"end":752},"obj":"Species"}],"attributes":[{"id":"A294","pred":"tao:has_database_id","subj":"294","obj":"Gene:1437"},{"id":"A322","pred":"tao:has_database_id","subj":"322","obj":"MESH:C000657245"},{"id":"A323","pred":"tao:has_database_id","subj":"323","obj":"MESH:D003711"},{"id":"A325","pred":"tao:has_database_id","subj":"325","obj":"MESH:C000657245"},{"id":"A330","pred":"tao:has_database_id","subj":"330","obj":"MESH:D009443"},{"id":"A331","pred":"tao:has_database_id","subj":"331","obj":"MESH:D004660"},{"id":"A332","pred":"tao:has_database_id","subj":"332","obj":"MESH:D004679"},{"id":"A333","pred":"tao:has_database_id","subj":"333","obj":"MESH:D009220"},{"id":"A357","pred":"tao:has_database_id","subj":"357","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":", and plexus, high CSF protein concentration but negative for COVID-19, typical features of acute demyelinating neuropathy by electrophysiology, and clinical improvement after IVIg.11\n\nGBS in the COVID-19 pandemic\nThese early GBS cases, despite incomplete immunologic workup considering the enormous difficulties in highly stressed in-hospital settings, provide early clues on what to expect in the months ahead regarding the common acute autoimmune neurologic conditions, such as GBS, polyneuritis cranialis, encephalitis, encephalomyelitis, or myositis, which for years we have been casually referring to as postviral if seen after febrile illnesses.\nFirst and foremost, the practicing neurologists in this pandemic should now be aware that a patient who presents with an acute paralyti"}

{"project":"LitCovid-sentences","denotations":[{"id":"T42","span":{"begin":185,"end":213},"obj":"Sentence"},{"id":"T43","span":{"begin":214,"end":652},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":", and plexus, high CSF protein concentration but negative for COVID-19, typical features of acute demyelinating neuropathy by electrophysiology, and clinical improvement after IVIg.11\n\nGBS in the COVID-19 pandemic\nThese early GBS cases, despite incomplete immunologic workup considering the enormous difficulties in highly stressed in-hospital settings, provide early clues on what to expect in the months ahead regarding the common acute autoimmune neurologic conditions, such as GBS, polyneuritis cranialis, encephalitis, encephalomyelitis, or myositis, which for years we have been casually referring to as postviral if seen after febrile illnesses.\nFirst and foremost, the practicing neurologists in this pandemic should now be aware that a patient who presents with an acute paralyti"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T77","span":{"begin":98,"end":111},"obj":"Phenotype"},{"id":"T78","span":{"begin":112,"end":122},"obj":"Phenotype"},{"id":"T79","span":{"begin":486,"end":498},"obj":"Phenotype"},{"id":"T80","span":{"begin":510,"end":522},"obj":"Phenotype"},{"id":"T81","span":{"begin":546,"end":554},"obj":"Phenotype"}],"attributes":[{"id":"A77","pred":"hp_id","subj":"T77","obj":"http://purl.obolibrary.org/obo/HP_0011096"},{"id":"A78","pred":"hp_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/HP_0009830"},{"id":"A79","pred":"hp_id","subj":"T79","obj":"http://purl.obolibrary.org/obo/HP_0031003"},{"id":"A80","pred":"hp_id","subj":"T80","obj":"http://purl.obolibrary.org/obo/HP_0002383"},{"id":"A81","pred":"hp_id","subj":"T81","obj":"http://purl.obolibrary.org/obo/HP_0100614"}],"text":", and plexus, high CSF protein concentration but negative for COVID-19, typical features of acute demyelinating neuropathy by electrophysiology, and clinical improvement after IVIg.11\n\nGBS in the COVID-19 pandemic\nThese early GBS cases, despite incomplete immunologic workup considering the enormous difficulties in highly stressed in-hospital settings, provide early clues on what to expect in the months ahead regarding the common acute autoimmune neurologic conditions, such as GBS, polyneuritis cranialis, encephalitis, encephalomyelitis, or myositis, which for years we have been casually referring to as postviral if seen after febrile illnesses.\nFirst and foremost, the practicing neurologists in this pandemic should now be aware that a patient who presents with an acute paralyti"}